UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

Displaying High-affinity Ligands on Adeno-associated Viral Vectors Enables Tumor Cell-specific and Safe Gene Transfer

Molecular therapy, 2013-01, Vol.21 (1), p.109-118

2013

Volltextzugriff (PDF)

Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platforms

Molecular therapy, 2022-07, Vol.30 (7), p.2401-2415

2022

Volltextzugriff (PDF)

DARPins: An Efficient Targeting Domain for Lentiviral Vectors

Molecular therapy, 2011-04, Vol.19 (4), p.686-693

2011

Volltextzugriff (PDF)

Surface-Engineered Viral Vectors for Selective and Cell Type-Specific Gene Delivery

Trends in biotechnology (Regular ed.), 2015-12, Vol.33 (12), p.777-790

2015

Volltextzugriff (PDF)

Virotherapy Research in Germany: From Engineering to Translation

Human gene therapy, 2017-10, Vol.28 (10), p.800

2017

Volltextzugriff (PDF)

Receptor-targeted lentiviral vectors are exceptionally sensitive toward the biophysical properties of the displayed single-chain Fv

Protein engineering, design and selection, 2015-04, Vol.28 (4), p.93-106

2015

Volltextzugriff (PDF)

Displaying Tetra‐Membrane Spanning Claudins on Enveloped Virus‐Like Particles for Cancer Immunotherapy

Biotechnology journal, 2018-03, Vol.13 (3), p.e1700345-n/a

2018

Volltextzugriff (PDF)

Lentiviral vectors targeted to MHC II are effective in immunization

Human gene therapy, 2011-10, Vol.22 (10), p.1249

2011

Volltextzugriff (PDF)

In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes

Molecular therapy, 2020-08, Vol.28 (8), p.1783-1794

2020

Volltextzugriff (PDF)

Targeted Cell Entry of Lentiviral Vectors

Molecular therapy, 2008-08, Vol.16 (8), p.1427-1436

2008

Volltextzugriff (PDF)

DARPin-targeting of Measles Virus: Unique Bispecificity, Effective Oncolysis, and Enhanced Safety

Molecular therapy, 2013-04, Vol.21 (4), p.849-859

2013

Volltextzugriff (PDF)

CD133-targeted Gene Transfer Into Long-term Repopulating Hematopoietic Stem Cells

Molecular therapy, 2015-01, Vol.23 (1), p.63-70

2015

Volltextzugriff (PDF)

Lentiviral vectors with measles virus glycoproteins – dream team for gene transfer?

Trends in biotechnology (Regular ed.), 2009-05, Vol.27 (5), p.259-265

2009

Volltextzugriff (PDF)

Identification of R-peptides in envelope proteins of C-type retroviruses

Journal of general virology, 2002-09, Vol.83 (9), p.2241-2246

2002

Volltextzugriff (PDF)

The European hospital exemption clause-new option for gene therapy?

Human gene therapy, 2012-01, Vol.23 (1), p.7

2012

Volltextzugriff (PDF)

In vitro incorporation of a cell-binding protein to a lentiviral vector using an engineered split intein enables targeted delivery of genetic cargo

Biotechnology and bioengineering, 2015-12, Vol.112 (12), p.2611-2617

2015

Volltextzugriff (PDF)

Is it going to be SIN?: a European Society of Gene Therapy commentary. Phasing-out the clinical use of non self-inactivating murine leukemia virus vectors: initiative on hold

The journal of gene medicine, 2006-10, Vol.8 (10), p.1274-1276

2006

Volltextzugriff (PDF)

Targeted Retroviral Vectors Displaying a Cleavage Site-engineered Hemagglutinin (HA) through HA-protease Interactions

Molecular therapy, 2006-11, Vol.14 (5), p.735-744

2006

Volltextzugriff (PDF)

Intrahepatic application of suicide gene-armed measles virotherapeutics: a safety study in transgenic mice and rhesus macaques

Human gene therapy. Clinical development, 2013-03, Vol.24 (1), p.11

2013

Volltextzugriff (PDF)

Chronic gene delivery of interferon-inducible protein 10 through replication-competent retrovirus vectors suppresses tumor growth

Cancer gene therapy, 2005-11, Vol.12 (11), p.900-912

2005

Volltextzugriff (PDF)

The proline-rich region of the ecotropic Moloney murine leukaemia virus envelope protein tolerates the insertion of the green fluorescent protein and allows the generation of replication-competent virus

Journal of general virology, 2003-02, Vol.84 (2), p.369-373

2003

Volltextzugriff (PDF)

Envelope proteins of spleen necrosis virus form infectious human immunodeficiency virus type 1 pseudotype vector particles, but fail to incorporate upon substitution of the cytoplasmic domain with that of Gibbon ape leukemia virus

Journal of general virology, 2006-06, Vol.87 (6), p.1577-1581

2006

Volltextzugriff (PDF)

Prion protein-specific antibodies for therapeutic intervention of transmissible spongiform encephalopathies

Expert opinion on biological therapy, 2006-03, Vol.6 (3), p.293-300

2006

Volltextzugriff (PDF)

In vivo selection of protease cleavage sites from retrovirus display libraries

Nature biotechnology, 1998-10, Vol.16 (10), p.951-954

1998

Volltextzugriff (PDF)

Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells

Cancer gene therapy, 2005-05, Vol.12 (5), p.464-474

2005

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Aktive Filter

ThemaBiotechnology & Applied Microbiology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(28)

Sprache

Englisch
(28)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(28)
Science & Technology
(28)
Animals
(19)
Humans
(18)
Medicine, Research & Experimental
(18)
Research & Experimental Medicine
(18)
Genetics & Heredity
(16)
Gene Therapy
(13)
Mice
(11)
Proteins
(10)
Genetic Vectors
(9)
Cell Line
(8)
Genetic Therapy - Methods
(7)
Lentivirus - Genetics
(7)
Biological And Medical Sciences
(6)
Fundamental And Applied Biological Sciences. Psychology
(6)
Transduction, Genetic
(6)
Vectors
(6)
Amino Acid Sequence
(5)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Displaying High-affinity Ligands on Adeno-associated Viral Vectors Enables Tumor Cell-specific and Safe Gene Transfer

Precision medicine: In vivo CAR therapy as a showcase for receptor-targeted vector platforms

DARPins: An Efficient Targeting Domain for Lentiviral Vectors

Surface-Engineered Viral Vectors for Selective and Cell Type-Specific Gene Delivery

Virotherapy Research in Germany: From Engineering to Translation

Receptor-targeted lentiviral vectors are exceptionally sensitive toward the biophysical properties of the displayed single-chain Fv

Displaying Tetra‐Membrane Spanning Claudins on Enveloped Virus‐Like Particles for Cancer Immunotherapy

Lentiviral vectors targeted to MHC II are effective in immunization

In Vivo Generation of CAR T Cells Selectively in Human CD4+ Lymphocytes

Targeted Cell Entry of Lentiviral Vectors

DARPin-targeting of Measles Virus: Unique Bispecificity, Effective Oncolysis, and Enhanced Safety

CD133-targeted Gene Transfer Into Long-term Repopulating Hematopoietic Stem Cells

Lentiviral vectors with measles virus glycoproteins – dream team for gene transfer?

Identification of R-peptides in envelope proteins of C-type retroviruses

The European hospital exemption clause-new option for gene therapy?

In vitro incorporation of a cell-binding protein to a lentiviral vector using an engineered split intein enables targeted delivery of genetic cargo

Is it going to be SIN?: a European Society of Gene Therapy commentary. Phasing-out the clinical use of non self-inactivating murine leukemia virus vectors: initiative on hold

Targeted Retroviral Vectors Displaying a Cleavage Site-engineered Hemagglutinin (HA) through HA-protease Interactions

Intrahepatic application of suicide gene-armed measles virotherapeutics: a safety study in transgenic mice and rhesus macaques

Chronic gene delivery of interferon-inducible protein 10 through replication-competent retrovirus vectors suppresses tumor growth

The proline-rich region of the ecotropic Moloney murine leukaemia virus envelope protein tolerates the insertion of the green fluorescent protein and allows the generation of replication-competent virus

Envelope proteins of spleen necrosis virus form infectious human immunodeficiency virus type 1 pseudotype vector particles, but fail to incorporate upon substitution of the cytoplasmic domain with that of Gibbon ape leukemia virus

Prion protein-specific antibodies for therapeutic intervention of transmissible spongiform encephalopathies

In vivo selection of protease cleavage sites from retrovirus display libraries

Replicating retroviral vectors mediating continuous production and secretion of therapeutic gene products from cancer cells

Aktive Filter

Suchergebnisse filtern